Prot #ABI-007-ST-001: A Phase 1, Open-Label, Multicenter, Safety Study of Nivolumab (BMS-936558) in Combination with nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or

Project: Research project

Project Details

StatusFinished
Effective start/end date11/11/1511/11/18

Funding

  • PPD Development (Prot #ABI-007-ST-001)
  • Celgene Corporation (Prot #ABI-007-ST-001)